OVERVIEW

Attorney Jim O’Brien’s primary focus is bringing justice for people who were hurt by:
  • dangerous prescription drugs,
  • faulty medical devices, and
  • abusive banking practices.
O’Brien has litigated against multiple corporate defendants, including:
  • Abbott Laboratories
  • AbbVie Pharmaceuticals
  • Actavis Inc.
  • Endo Pharmaceuticals
  • Howmedica Osteonics Corp.
  • Merck
  • Pfizer
  • ProMedica
  • Stryker Corporation
  • Watson Pharmaceuticals
  • Wells Fargo
“

"There is absolutely nothing you can throw at this man that he can't deal with or know where to find the answer as to how to deal with. He has one of the broadest intellects i have ever come across in such a humble human being."

Former Client
“

"I am sooooo, very excited & can’t thank you enough! Your professionalism & dedication has been top notch & I appreciate you more than you know. THANK YOU!!! "

Former Pharmaceutical Client
“

"I know I always thank you for the great job you do, but I don't think can thank you ENOUGH for the phenomenal job you did in helping move this case along and get it to the finish line."

Former Co-Counsel on a Death Case

OUR BLOG

Court of Appeals Rejects J&J Bankruptcy Attempt

| Roundup, Uncategorized | No Comments
The Third Circuit Federal Court of Appeals rejected an attempt by Johnson and Johnson to use Bankruptcy to avoid talcum powder litigation. This is a significant win for plaintiffs who…

O’Brien to Lead Lucas County Bar Association

| Uncategorized | No Comments
Attorney James O'Brien was elected the 2023 President of the Lucas County Bar Association located in Toledo Ohio. An installation ceremony was held on January 9, 2023. Incoming Lucas County…

AbbVie Asks Court to Grant Summary Judgment in 3 Cases

| AndroGel | No Comments
Pharmaceutical conglomerate AbbVie--the maker of AndroGel--has asked the Court to grant it summary judgment in the 3 remaining AndroGel-related cases. The company pulled out a variety arguments in an attempt…

Court of Appeals Rejects EPA’s Safety Analysis of Glyphosate

| Roundup | No Comments
In a decision issued on June 17, 2022, the Ninth Circuit Federal Court of Appeals rejected the EPA's review of glyphosate, which is the active chemical ingredient in Roundup herbicide.…

Supreme Court Won’t Hear Monsanto’s Preemption Argument

| Roundup | No Comments
Supreme Court Won't Hear Monsanto's Preemption Argument After losing two trials, Monsanto filed Petitions for Certiorari with the U.S. Supreme Court, asking the Court to overturn the verdicts against it:…

Plaintiff Accuses Actavis of Concealing Evidence During Trial

| AndroGel | No Comments
Plaintiff Accuses Actavis of Concealing Evidence During Trial